Abstract:Background Skin fibrosis is the typical pathological manifestation of systemic sclerosis (SSc) and localized scleroderma (LS); it has an unclear aetiology and few effective treatments. Although excessive collagen secretion by fibroblasts is the primary cause of skin fibrosis, evidence has suggested that vascular damage is the initiating event and that various cell types, including fibroblasts, work together to contribute to the pathogenesis of skin fibrosis.Objectives To explore the relationship between vascular endothelial cell lesions and immune cell infiltration, along with the interactions between various cell types within the fibrotic skin ecosystem.Methods Single-cell RNA sequencing was performed on skin biopsies from three healthy donors and seven patients with SSc. Additional data from three patients with localized scleroderma available in the Gene Expression Omnibus (GSE160536) were integrated by Harmony. CellChat (version 1.5.0) was used to analyse the cell communication network. A Transwell (R) assay and a bleomycin (BLM) mouse model were used to explore the role of atypical chemokine receptor 1 (ACKR1; 'Duffy antigen') in immune cell infiltration. Milo single-cell Western blot was used to show fibroblast subcluster activation.Results A total of 62 295 cells were obtained and subpopulations of stromal and immune cells identified. Interaction network analysis found that multiple chemokines secreted by macrophages, pericytes and proinflammatory fibroblasts could bind with ACKR1, which was highly expressed by endothelial cells in lesional skin. The Transwell (R) assay revealed that overexpression of ACKR1 in human umbilical vein endothelial cells facilitated leucocyte infiltration following treatment with interleukin-8. BLM mice showed enhanced ACKR1 expression, massive immune cell infiltration and skin fibrosis that was attenuated by ACKR1 inhibition. Furthermore, infiltrated macrophages expressing high levels of transforming growth factor (TGF)-beta 1 or platelet-derived growth factor B (PDGFB) could activate secreted frizzled-related protein 2 (SFRP2)/asporin (ASPN)+ fibroblasts to contribute to the excessive accumulation of extracellular matrix. It was also found that the SOX4-ASPN axis plays an important role in the TGF-beta signalling cascade and the aetiology of skin fibrosis.Conclusions Our results reveal that high expression of ACKR1 by endothelial cells in fibrotic skin tissue promotes immune cell infiltration and that SFRP2/ASPN+ fibroblasts synergize to exacerbate skin fibrosis. Graphical Abstract We performed a systemic characterization of the interactions between various cell types in fibrotic skin tissues, providing novel insights into the mechanism of skin fibrosis. We identified a cluster of atypical chemokine receptor 1 (ACKR1)+ endothelial cells that are highly expressed in fibrotic skin tissue, and found that ACKR1+ endothelial cells could promote immune cell infiltration and mediate the development of skin fibrosis, providing a theoretical basis for potential anti-ACKR1 treatment in skin fibrosis. Infiltrating macrophages activated SFRP2/ASPN+ fibroblasts by secreting TGF-beta 1 and PDGFB, suggesting a role of macrophage-fibroblast interactions in skin fibrosis. The SOX4-ASPN axis plays an important role in the TGF-beta signalling cascade and aetiology of skin fibrosis. Skin fibrosis is characterized by thickening or hardening of the skin. It occurs in a number of skin diseases. It has been suggested that different cell types work together to contribute to the processes involved in skin fibrosis.In this study, we looked at interactions between different cell types involved in two different fibrotic skin diseases called 'systemic sclerosis' and 'localized scleroderma'. We found that many signalling proteins produced by certain cell types interacted strongly with a protein called 'ACKR1'. Other investigations showed that high levels of ACKR1 aggravated skin fibrosis. Finally, 'macrophages' (a type of white blood cell) that produced high levels of two different proteins caused skin fibrosis to worsen.Overall, our study findings provide a deeper insight into cellular interactions that might cause skin fibrosis to develop. This may lead to new treatments for these two diseases.

Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin

Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase–like 4: New Evidence from Three‐Dimensional Skin‐like Tissues

Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease

Single-cell epigenomic dysregulation of Systemic Sclerosis fibroblasts via CREB1/EGR1 axis in self-assembled human skin equivalents

Fibroblast subpopulations in Systemic Sclerosis - Functional implications of individual subpopulations and correlations with clinical features

A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis

Alternative splicing and intron retention: Their profiles and roles in cutaneous fibrosis of systemic sclerosis

Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma

The role and mechanism of CRISPLD2 in skin fibrosis of systemic sclerosis

Altered AP-1, RUNX, and EGR chromatin dynamics drive fibrotic lung disease

LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma

Atypical Chemokine Receptor 1-Positive Endothelial Cells Mediate Leucocyte Infiltration and Synergize with Secreted Frizzled-Related Protein 2/Asporin-Positive Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis.

RUNX1 is Expressed in a Subpopulation of Dermal Fibroblasts and Higher RUNX1 Levels are Associated with the Severity of Systemic Sclerosis

ACKR1+ Endothelial Cells Mediate Leukocyte Infiltration and Synergize with SFRP2/ASPN+ Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis

Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease

Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis

SLC39A7 upregulation links to skin fibrosis in systemic sclerosis via TGF‐β/SMAD pathway

Molecular Features and Stages of Pulmonary Fibrosis Driven by Type 2 Inflammation

TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis

Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis

Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms